Clinical Trial Update: NE3107 Activity and Safety in Patients With Parkinson's Disease Using Levodopa [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update on NE3107 for Parkinson's disease patients using levodopa, evaluating activity and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• NE3107 (NE3107)

Snippet

Sponsor: BioVie Inc. | Conditions: Parkinson Disease | Phase 1, Phase 2 | Status: COMPLETED